CTOs on the Move

SAB Biotherapeutics

www.sabbiotherapeutics.com

 
SAB Biotherapeutics, Inc. (SAB) is a clinical-stage, biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. SAB has applied advanced genetic engineering and antibody science to develop transchromosomic (Tc) Bovine™ herds that produce fully-human antibodies targeted at specific diseases, including infectious diseases such as COVID-19 and influenza, immune system disorders including type 1 diabetes and organ transplantation, and cancer. SAB`s versatile DiversitAb™ platform is appliable to a wide range of serious unmet needs in human diseases. It produces natural, specifically targeted, high-potency, human polyclonal immunotherapies. SAB is currently advancing multiple clinical programs and has a number ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
David Miller
 Senior Director of Information Technology and Security Profile

Funding

SAB Biotherapeutics raised $22M on 12/20/2018
SAB Biotherapeutics raised $14M on 07/17/2020

Similar Companies

SSCI

SSCI is a West Lafayette, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rodeo Dental & Orthodontics

Rodeo Dental & Orthodontics has 100+ dental experts from several specialties! Your one-stop shopping in STYLE for all your oral health needs.

Attune Pharmaceuticals

Attune Pharmaceuticals is a private biotechnology company focused on discovering and developing novel orally-administered small-molecule therapeutics for the treatment of rare diseases.

NeurAbilities Healthcare

The premier provider of comprehensive and coordinated neurological and behavioral services in New Jersey and Pennsylvania, offering comfort, hope and answers that transform individuals and their families.

Immune-Onc Therapeutics

Immune-Onc Therapeutics, Inc. is a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients.